We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
168 hedge funds and large institutions have $316M invested in Anavex Life Sciences in 2024 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 50 increasing their positions, 39 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
114% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 22
106% more capital invested
Capital invested by funds: $153M → $316M (+$163M)
63% more call options, than puts
Call options by funds: $15.9M | Put options by funds: $9.78M
28% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 39
16% more funds holding
Funds holding: 145 → 168 (+23)
3.02% more ownership
Funds ownership: 31.82% → 34.84% (+3%)
Holders
168
Holders Change
+23
Holders Change %
+15.86%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
47
Increased
50
Reduced
39
Closed
22
Calls
$15.9M
Puts
$9.78M
Net Calls
+$6.14M
Net Calls Change
+$6.04M
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.89M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$4.54M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
+$3.4M |
| 4 |
EP
Essential Planning
Portsmouth,
New Hampshire
|
+$3.18M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.22M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$5.03M |
| 2 |
BlackRock
New York
|
-$1.45M |
| 3 |
Millennium Management
New York
|
-$1.02M |
| 4 |
Goldman Sachs
New York
|
-$950K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$723K |
